CRAB

News

Roche takes new antibiotic into phase 3 for 'urgent threat'

Roche is moving its antibiotic zosurabalpin into phase 3 for CRAB, potentially a big step forward in the fight against antimicrobial resistance.

News

Novo Nordisk Foundation puts $25m into AMR programme

The Novo Nordisk Foundation has come up with more funding to help battle the scourge of antimicrobial resistance (AMR), putting $25 million into a non-profit accelerator p

News

Roche antibiotic tackles serious drug-resistant pathogen

Scientists at Roche and Harvard University have discovered an entirely new class of antibiotic that can kill a highly drug-resistant ‘superbug’ with a mortality rate that can be upwar

Roche takes new antibiotic into phase 3 for 'urgent threat'

Novo Nordisk Foundation puts $25m into AMR programme

Roche antibiotic tackles serious drug-resistant pathogen

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks